Inclusion Criteria:  undetectable PSA (<0.02 ng/ml) within 8 weeks post-operative; ≥25% predicted risk of PSA recurrence within 5 years of surgery (based on the Kattan nomogram)  Exclusion Criteria:  Unwilling to receive ADT; previously received ADT; lymph node metastases allergy to any form of ADT